Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial
Llanos-Cuentas et al., BMC Research Notes, doi:10.1186/s13104-023-06281-7
https://c19hcq.org/llanoscuentas.html